# Post-thrombotic syndrome

Condition · id `cardio:post-thrombotic-syndrome` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: PTS; Postthrombotic syndrome

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

Post-thrombotic syndrome (PTS) is a long-lasting problem that can follow a deep vein thrombosis (DVT), a blood clot in a deep vein. MeSH describes it as a condition caused by one or more episodes of DVT, usually with clots in the legs, with swelling, pain, aching, heaviness and muscle cramp in the leg; when severe swelling breaks down the skin, it is called a venous stasis ulcer. Two open-access reviews (2023 and 2025) call it a common complication of DVT, and the 2023 review says it affects up to 50 percent of people with DVT. The 2025 review says there is no definitive way to prevent it entirely or to treat it once it is established, and that preventing DVT remains the cornerstone of lowering how often it occurs. The 2023 review says effective anticoagulation lowers the risk, and that the evidence for elastic compression stockings and for catheter-based clot dissolving or removal is unclear; the 2025 review calls the evidence limited for stockings and stronger, with limits, for catheter-directed treatment. This page gives no advice on prevention or treatment.

## Technical summary

MeSH descriptor D054070 (Postthrombotic Syndrome); its scope note is the basis for the symptom list above. The 2025 review (Health Science Reports) says diagnosis is largely clinical, that the Villalta scale and CEAP classification give objective measures with limited accuracy and reliability, that the syndrome is characterized by chronic venous insufficiency and persistent venous hypertension, and that it lacks standardized diagnostic criteria. That review excluded studies in children, so these statements are about adults. The 2023 review (International Journal of Hematology) puts the burden at up to 50 percent of people with DVT and says there are few effective, proven options once the syndrome is established. The text rests on the MeSH scope note and these two reviews.

## Connected pages

- A review says post-thrombotic syndrome is characterized by chronic venous insufficiency: Chronic venous insufficiency (`cardio:chronic-venous-insufficiency`)
- Filed under this front: Medicines (`cardio:front-medicines`)
- Post-thrombotic syndrome is a complication of deep vein thrombosis: Deep vein thrombosis (`cardio:deep-vein-thrombosis`)
- Compression stockings are studied for preventing and treating it: Compression therapy for veins and lymph (`cardio:compression-therapy-for-veins-and-lymph`)
- Reviews discuss catheter-directed treatment for prevention and treatment: Catheter-directed therapy for pulmonary embolism and DVT (`cardio:catheter-directed-therapy-for-pulmonary-embolism-and-dvt`)
- A review says effective anticoagulation lowers the risk: Anticoagulants (`cardio:anticoagulants`)
- The review says direct oral anticoagulants appear to outperform vitamin-K antagonists: Direct oral anticoagulants (DOACs) (`cardio:direct-oral-anticoagulants-doacs`)

## Provenance

Content hash: ef6556bbbfa27c0444e16f82d1efeccbc947261adcaaf1e37e57da4d0173055d
Last substantive edit: 2026-11-18
Evidence last checked: 2026-11-18
